Connect Sign In
LabMind podcasts
As part of an ongoing recruitment fraud scheme, scammers posing as ARUP recruiters are targeting job seekers on LinkedIn. |
December 29, 2023 |
Bad Actors Target Job Seekers in Ongoing Recruitment Fraud Schemes Scammers posing as ARUP recruiters on LinkedIn have attempted to collect sensitive information from job seekers. ARUP recommends that potential applicants approach job offers with caution. |
Melanie Mallory, MS, lead bioinformatics scientist at ARUP Laboratories, played a key role in the development and validation of ARUP’s Cytomegalovirus Drug Resistance by Next Generation Sequencing assay. |
December 19, 2023 | Next generation sequencing provides a more rigorous and sensitive method to identify drug-resistant variants of cytomegalovirus, which enables earlier detection and more effective treatment. |
From left to right: Nermin Uvejzovik, Staci Beck, Aubrie Smith, Mitzi Irish, Carrie Pederson, and Derek Gleue accept their third place award in the annual Pipetting Challenge. Not pictured: Sheri Mitchell, Wendy Dong, Cindy Kuo, and Kris Moore. |
December 11, 2023 |
Seven ARUP Teams Finish in the Top 10 in National Pipetting Challenge More than 250 ARUP employees participated in Advanced Instruments’ Pipetting Challenge this year. Seven ARUP teams finished in the top 10 in the nationwide competition. |
Madhu Menon, MD, PhD, FCAP, ARUP’s section chief of Hematopathology, works with a team of experts to deliver accurate and timely results. |
December 7, 2023 | PhD scientists, analysts, and medical directors within ARUP’s Hematopathology department meet often to ensure clinicians and patients receive a diagnosis that reflects an integrated approach. |
The AAV5 DetectCDx™ Kit received its Conformitée Européene (CE) mark in January 2022, and testing is being performed by a Medicover facility in Germany. |
December 6, 2023 |
Partnership Between ARUP and Medicover Expands Access to Companion Diagnostic in the European Union ARUP and Medicover have partnered to provide a new companion diagnostic test to European Union patients. The test helps identify individuals eligible for a new gene therapy for severe hemophilia A. |
Utah Business magazine has honored ARUP Laboratories with a 2023 Best Companies to Work For Award. ARUP has earned this award every year since 2018. |
December 1, 2023 |
ARUP Laboratories Honored With 2023 Best Companies to Work For Award From Utah Business Magazine Utah Business magazine honored ARUP Laboratories with its Best Companies to Work For award for the sixth consecutive year based on anonymous employee survey results. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine We accelerate groundbreaking diagnostic and prognostic technologies to drive life-changing innovation. Our large, single-site operation and renowned quality framework, combined with our extensive expertise, provide an ideal incubator to advance custom projects for innovative partners. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat